2024 Senate Bill 822

Probate: patient advocates; withholding life-sustaining treatment for a patient who is pregnant; allow.

A bill to amend 1998 PA 386, entitled “Estates and protected individuals code,” by amending section 5507 (MCL 700.5507), as amended by 2024 PA 1.

AI Analysis – Experimental

Senate Bill No. 822 proposes amendments to the 1998 PA 386, known as the "Estates and protected individuals code," specifically targeting section 5507. The bill aims to refine the patient advocate designation process, emphasizing the inclusion of the patient's preferences regarding care, custody, medical or mental health treatment, life-sustaining treatment during pregnancy, and the making of anatomical gifts. It ensures that a patient's pregnancy status does not restrict these rights.

Key provisions of the bill include:

A detailed process for designating a patient advocate, which requires the advocate's acceptance and outlines their decision-making authority, including post-death decisions related to anatomical gifts. A prohibition against patient advocates receiving compensation, though they may be reimbursed for necessary expenses. The requirement for patient advocates to adhere to fiduciary standards and act in the patient's best interests, with the patient's known desires presumed to be in their best interest. The patient's right to revoke the patient advocate designation at any time, with provisions allowing for the designation of a successor patient advocate. Specific conditions under which a patient advocate may make decisions to withhold or withdraw life-sustaining treatment, emphasizing the need for clear and convincing expression of the patient's wishes by the patient.

Introduced in the Senate

April 10, 2024

Introduced by Sen. Sarah Anthony (D-21) and five co-sponsors

Co-sponsored by Sens. Erika Geiss (D-1), Stephanie Chang (D-3), Sylvia Santana (D-2), John Cherry (D-27) and Mary Cavanagh (D-6)

Referred to the Committee on Housing and Human Services

Oct. 16, 2024

Reported without amendment

Oct. 17, 2024

Referred to the Committee of the Whole

Oct. 30, 2024

Reported without amendment